Marta Batus on the New Direct-to-Consumer Advertising for Nivolumab, and Its Impact on Oncology Practice.
Marta
M
Batus
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000067088:Direct-to-Consumer Advertising; D006801:Humans; D008495:Medical Oncology / Q000191:economics* / Q000458:organization & administration*; D009369:Neoplasms / Q000188:drug therapy; D000077594:Nivolumab; D014481:United States
D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D000077594:Nivolumab